Bill Caragol, CFO of Mainz BioMed (NASDAQ:MYNZ), was recently a guest on Benzinga's All-Access. Mainz BioMed, maker of clinical laboratory tests, says it is committed to saving lives and reducing healthcare costs through early disease detection and prevention. For cancer and chronic conditions,…
Continue reading...